YPF S.A.-SPONSORED ADR (YPF) Stock Cash Flow
NYSE:YPF • US9842451000
Current stock price
45.17 USD
+1.49 (+3.41%)
At close:
45.9 USD
+0.73 (+1.62%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -1048.27B | 2122.82B | -1532.74B | 290.26B | -808.00M | |||
| Depreciation Amortization | 3990.47B | 2550.11B | 988.62B | 372.57B | 291.72B | |||
| Change In Working Capital | -1260.40B | 373.63B | 215.56B | -31.19B | -44.57B | |||
| Interest Paid | 820.36B | 645.08B | 214.03B | 73.12B | 58.45B | |||
| Taxes Paid | 206.11B | 29.22B | 7.74B | 44.93B | 598.00M | |||
| Other non cash items | 4799.25B | 552.59B | 2102.77B | 105.01B | 153.67B | |||
| OPERATING CASH FLOW | 6481.04B | 5599.15B | 1774.20B | 736.66B | 400.01B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -6391.57B | -5138.97B | -1590.93B | -532.13B | -234.80B | |||
| Other Investing Activity | -668.11B | -90.07B | 68.70B | 9.10B | -9.19B | |||
| INVESTING CASH FLOW | -7059.68B | -5229.04B | -1522.23B | -523.02B | -243.99B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 1375.82B | 354.52B | 249.65B | -78.52B | -92.12B | |||
| Stock Issued/Repurchased | -14.03B | 0.00 | 0.00 | -4.24B | 0.00 | |||
| Dividend Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Financing Activity | -835.00B | -648.18B | -216.49B | -74.34B | -58.54B | |||
| FINANCING CASH FLOW | 526.78B | -293.66B | 33.16B | -157.10B | -150.66B | |||
| Exchange Rate Effect | 252.69B | 169.46B | 483.94B | 17.66B | 2.70B | |||
| CHANGE IN CASH | 200.84B | 245.91B | 769.08B | 74.20B | 8.06B | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 6481.04B | 5599.15B | 1774.20B | 736.66B | 400.01B | |||
| Capital Expenditure | -6391.57B | -5138.97B | -1590.93B | -532.13B | -234.80B | |||
| FREE CASH FLOW | 89.47B | 460.18B | 183.27B | 204.53B | 165.21B | |||
All data in ARS